Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Giles

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|April 1, 1996
Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivoY A Senis, M Richardson, S Tinlin, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1994
Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivoM Richardson, S Tinlin, M De Reske, et al.
Blood|July 1, 1988
In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency)A R Giles, S Tinlin, H Hoogendoorn, et al.
Blood|February 1, 1982
The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbitsA R Giles, M E Nesheim, H Hoogendoorn, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1995
Cell layer-specific expression of cyclic nucleotide phosphodiesterases in rat arteries: molecular cloning using isolated cell layers from paraformaldehyde-fixed tissuesD H Maurice, Y A Senis, H Liu, et al.
British Journal of Haematology|July 1, 1982
Stroma free human platelet lysates potentiate the in vivo thrombogenicity of factor Xa by the provision of coagulant-active phospholipidA R Giles, M E Nesheim, H Hoogendoorn, et al.
Blood|August 1, 1997
Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor VJ A Samis, M Garrett, R P Manuel, et al.
Blood|March 1, 1980
Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopeniaJ G Kelton, A R Giles, P B Neame, et al.
Journal of Clinical Apheresis|January 1, 1984
A controlled trial of plasma exchange in rheumatoid arthritisA R Giles, I L Dwosh, P M Ford, et al.
The New England Journal of Medicine|May 12, 1983
Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trialI L Dwosh, A R Giles, P M Ford, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|April 1, 1996
Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivoY A Senis, M Richardson, S Tinlin, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1994
Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivoM Richardson, S Tinlin, M De Reske, et al.
Blood|July 1, 1988
In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency)A R Giles, S Tinlin, H Hoogendoorn, et al.
Blood|February 1, 1982
The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbitsA R Giles, M E Nesheim, H Hoogendoorn, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1995
Cell layer-specific expression of cyclic nucleotide phosphodiesterases in rat arteries: molecular cloning using isolated cell layers from paraformaldehyde-fixed tissuesD H Maurice, Y A Senis, H Liu, et al.
British Journal of Haematology|July 1, 1982
Stroma free human platelet lysates potentiate the in vivo thrombogenicity of factor Xa by the provision of coagulant-active phospholipidA R Giles, M E Nesheim, H Hoogendoorn, et al.
Blood|August 1, 1997
Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor VJ A Samis, M Garrett, R P Manuel, et al.
Blood|March 1, 1980
Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopeniaJ G Kelton, A R Giles, P B Neame, et al.
Journal of Clinical Apheresis|January 1, 1984
A controlled trial of plasma exchange in rheumatoid arthritisA R Giles, I L Dwosh, P M Ford, et al.
The New England Journal of Medicine|May 12, 1983
Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trialI L Dwosh, A R Giles, P M Ford, et al.
Pageof 8